MSH|^~\&|LAB|LMH|||201912311201||ORU^R01|4137319|D|2.3|||AL|NE
PID|1||LM00005478|LM5311|PHATEST^LUMED5^||19390301|M||||||||||LX000017/19|
OBR|1|37378^LAB|00028102^3112:C00014R^LAB^311219:C14^37378|530.7900^TOBT^Tobramycin Trough Level^^^4059-2||201912311144|201912310810|||||||201912311143||||||||||LAB|F||||
OBX|1|ST|500.2600^CR^Creatinine Modified Jaffe^^14682-9^14682-9|1|105^^Y|umol/L|45-110|N||A^S|F|||201912311145
OBX|2|ST|500.2700^EGFR^Glomerular Filtration Rate Est^^33914-3^33914-3|1|58^^Y|mL/min|>60|L||A^S|F|||201912311145
OBX|3|ST|530.7970^TOBT R^Tobramycin Trough^L TOBP^4059-2^4059-2|1|< 0.5^^Y|mg/L|0.0-1.9|N||A^S|F|||201912311145
NTE|1||Desired Serum Trough (Pre) Levels
NTE|2||  Once a day dosing: Less than 1.0 mg/L
NTE|3||Conventional dosing: Less than 2.0 mg/L